Data compiled on the alteration frequencies using the CBioPortal Cancer Genomics shows that ~40% of BC patients had PIK3CA alterations, followed by 11% having PTEN deletion [Figure 1A]. This evidence concerns the gene PIK3CA and breast cancer.